Pacific Biosciences (PACB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2016 | 12-2015 | 09-2015 | 06-2015 | 03-2015 | |
| Sales | 19,127 | 36,281 | 13,917 | 24,939 | 17,645 |
| Cost of Goods | 9,623 | 9,815 | 7,366 | 10,433 | 11,718 |
| Gross Profit | 9,504 | 26,466 | 6,551 | 14,506 | 5,927 |
| Operating Expenses | 28,692 | 28,343 | 4,303 | 26,297 | 25,973 |
| Operating Income | -18,565 | -1,062 | 2,614 | -11,358 | -19,328 |
| Interest Expense | 779 | 773 | 741 | 715 | 697 |
| Other Income | -8 | 426 | -52 | 138 | -148 |
| Pre-tax Income | -19,352 | -1,409 | 1,821 | -11,935 | -20,173 |
| Net Income Continuous | -19,352 | -1,409 | 1,821 | -11,935 | -20,173 |
| Net Income | $-19,352 | $-1,409 | $1,821 | $-11,935 | $-20,173 |
| EPS Basic Total Ops | -0.23 | -0.01 | 0.02 | -0.16 | -0.27 |
| EPS Basic Continuous Ops | -0.23 | -0.01 | 0.02 | -0.16 | -0.27 |
| EPS Diluted Total Ops | -0.23 | -0.01 | 0.02 | -0.16 | -0.27 |
| EPS Diluted Continuous Ops | -0.23 | -0.01 | 0.02 | -0.16 | -0.27 |
| EBITDA(a) | $-17,449 | $179 | $3,708 | $-10,187 | $-18,200 |